Gene · 3777
Papers1,851
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,851
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Low OLFM1 and BMP6 Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance. | Cancer Res Commun | 2025 | 41259663 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomization identifies β-nerve growth factor as a target for endometriosis. | Medicine (Baltimore) | 2025 | 41239706 | PubTator, text mining | PubMed |
| Investigating the causal role of cellular senescence-related genes in preeclampsia: a multi-omics Mendelian randomization study with differential expression analysis. | Front Endocrinol (Lausanne) | 2025 | 41220585 | PubTator, text mining | PubMed |
| Profiling Interactions Between Bicyclol and SLC/ABC Transporters: Advancing Clinical Safety and Efficacy in Combination Therapy. | Pharm Res | 2025 | 41145746 | PubTator, text mining | PubMed |
| Exploring the causal relationship between plasma proteins and postherpetic neuralgia: a Mendelian randomization study. | Front Neurol | 2025 | 41142151 | PubTator, text mining | PubMed |
| Pathogenic Glomulin Gene Variant in a Patient with Idiopathic Pulmonary Arterial Hypertension: A Novel Association Case Report. | Reports (MDPI) | 2025 | 41133550 | PubTator, text mining | PubMed |
| Causal plasma metabolites for breast cancer risk: a two-sample Mendelian randomization study with colocalization evidence. | Discov Oncol | 2025 | 41105334 | PubTator, text mining | PubMed |
| SPAmix: a scalable, accurate, and universal analysis framework for large-scale genetic association studies in admixed populations. | Genome Biol | 2025 | 41102819 | PubTator, text mining | PubMed |
| Integrated Single-Cell RNA Sequencing and Proteome-Wide Mendelian Randomization Identifies Therapeutic Targets for Psoriasis and Associated Complications. | Psoriasis (Auckl) | 2025 | 41098849 | PubTator, text mining | PubMed |
| Evaluation of gene and microRNA expression patterns in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as rare diseases. | Respir Med | 2025 | 41072776 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomization and colocalization analysis identify therapeutic targets for cutaneous melanoma. | Medicine (Baltimore) | 2025 | 40988203 | PubTator, text mining | PubMed |
| Exploring the Protein-Metabolite Interplay to Discover Novel Drug Targets for Alzheimer's Disease. | J Gene Med | 2025 | 40974265 | PubTator, text mining | PubMed |
| Identifying potential therapeutic targets for prostate cancer with mediating role in tumor immunity. | Discov Oncol | 2025 | 40947455 | PubTator, text mining | PubMed |
| TREK-1 and epilepsy: regulating the balance of K+ and the glutamate release in astrocyte-neuron interactions. | Behav Brain Funct | 2025 | 40887605 | PubTator, text mining | PubMed |
| Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine. | Ther Adv Respir Dis | 2025 | 40878965 | PubTator, text mining | PubMed |
| Potential role of DKK3 and WIF1 in prostate cancer: bioinformatics and clinical analysis. | Discov Oncol | 2025 | 40864208 | PubTator, text mining | PubMed |
| The Causal Role of the Gut Microbiota-Plasma Metabolome Axis in Myeloproliferative Neoplasm Pathogenesis: A Mendelian Randomization and Mediation Analysis. | Metabolites | 2025 | 40863120 | PubTator, text mining | PubMed |
| Pinpointing novel targets for osteoarthritis: A comprehensive cross-omics integration analysis. | Medicine (Baltimore) | 2025 | 40859561 | PubTator, text mining | PubMed |
| Response splicing quantitative trait loci in primary human chondrocytes identify putative osteoarthritis risk genes. | Nat Commun | 2025 | 40858580 | PubTator, text mining | PubMed |
| Identifying potential drug targets for postoperative abdominal wall hernia using Mendelian randomization: a multi-omics study. | Sci Rep | 2025 | 40855105 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3777/papers?page=6